Cryoballoon ablation for persistent atrial fibrillation in patients without left atrial fibrosis.
Michael GramlichCarole MaleckJonathan MarquardtMartin DuckheimFabian StimpfleDavid HeinzmannChristian ScheckenbachMeinrad GawazJürgen SchreieckPeter SeizerPublished in: Journal of cardiovascular electrophysiology (2019)
In patients with persistent AF undergoing CB PVI, the extent of left atrial LVAs predicts an AF-free survival. CB PVI seems to be a highly effective treatment for patients with persistent AF without atrial fibrosis.
Keyphrases
- atrial fibrillation
- left atrial
- catheter ablation
- oral anticoagulants
- left atrial appendage
- free survival
- direct oral anticoagulants
- end stage renal disease
- heart failure
- percutaneous coronary intervention
- newly diagnosed
- ejection fraction
- chronic kidney disease
- mitral valve
- peritoneal dialysis
- patient reported outcomes
- coronary artery disease
- liver fibrosis
- radiofrequency ablation